Barrington analyst Michael Petusky downgraded Opko Health (OPK) to Market Perform from Outperform with no price target The firm previously had expected BRH break-even or profitability in 2026 and now feels that this is “highly unlikely to materialize,” the analyst tells investors. The firm also now views the upper end of the company’s FY26 guidance as “seriously aspirational,” the analyst added.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OPK: